Rural Health
Resources by Topic: Pharmacy and prescription drugs
The Approaching End of the COVID-19 Public Health Emergency and Its Implications for RHCs
Outlines Rural Health Clinic (RHC)-specific waivers implemented in response to the COVID-19 pandemic and will end at the conclusion of the public health emergency (PHE). Highlights how other policies will be impacted by the end of the PHE, including telehealth flexibilities; Medicaid redetermination; the commercialization of COVID-19 vaccines, treatments, and tests; and Emergency Use Authorizations.
Date: 02/2023
Type: Document
Sponsoring organization: National Association of Rural Health Clinics
view details
Outlines Rural Health Clinic (RHC)-specific waivers implemented in response to the COVID-19 pandemic and will end at the conclusion of the public health emergency (PHE). Highlights how other policies will be impacted by the end of the PHE, including telehealth flexibilities; Medicaid redetermination; the commercialization of COVID-19 vaccines, treatments, and tests; and Emergency Use Authorizations.
Date: 02/2023
Type: Document
Sponsoring organization: National Association of Rural Health Clinics
view details
COVID-19 Booster Vaccination in Rural Community Pharmacies
Examines perceptions surrounding COVID-19 booster vaccinations in rural southeastern community pharmacies. Utilizes February-March 2022 survey data from 112 pharmacists part of the the Rural Research Alliance of Community Pharmacies (RURAL-CP) and analyzes number of pharmacies offering COVID-19 booster vaccinations, reasons for choosing versus not choosing vaccination, barriers to COVID-19 booster vaccinations, and more.
Author(s): Abigail Gamble, Tessa J. Hastings, Salisa C. Westrick, et al.
Citation: Vaccine, 41(5), 999-1002
Date: 01/2023
Type: Document
view details
Examines perceptions surrounding COVID-19 booster vaccinations in rural southeastern community pharmacies. Utilizes February-March 2022 survey data from 112 pharmacists part of the the Rural Research Alliance of Community Pharmacies (RURAL-CP) and analyzes number of pharmacies offering COVID-19 booster vaccinations, reasons for choosing versus not choosing vaccination, barriers to COVID-19 booster vaccinations, and more.
Author(s): Abigail Gamble, Tessa J. Hastings, Salisa C. Westrick, et al.
Citation: Vaccine, 41(5), 999-1002
Date: 01/2023
Type: Document
view details
Rural Americans' COVID-19 Vaccine Perceptions and Willingness to Vaccinate against COVID-19 with Their Community Pharmacists: An Exploratory Study
Presents a study on the perceptions of rural people on the COVID-19 vaccine and their willingness to receive a vaccine from their community pharmacist. Bases findings on phone-based interviews with rural adults. Breaks down data by age, sex, and education, among other measures.
Author(s): Alexis M. Koskan, Iris E. LoCoco, Casey L. Daniel, et al.
Citation: Vaccines, 11(1), 171
Date: 01/2023
Type: Document
view details
Presents a study on the perceptions of rural people on the COVID-19 vaccine and their willingness to receive a vaccine from their community pharmacist. Bases findings on phone-based interviews with rural adults. Breaks down data by age, sex, and education, among other measures.
Author(s): Alexis M. Koskan, Iris E. LoCoco, Casey L. Daniel, et al.
Citation: Vaccines, 11(1), 171
Date: 01/2023
Type: Document
view details
Challenges with Vaccination Data Hinder State and Local Immunization Program Efforts to Combat COVID-19
Presents results of a December 2021 survey of 56 state and local immunization programs regarding whether they receive individual-level COVID-19 vaccination data from Federal agencies and retail pharmacy partners. Discusses the impact of having incomplete individual-level vaccination data on reaching unvaccinated and vulnerable populations, including rural populations and American Indians and Alaska Natives (AI/ANs). Includes recommendations for the CDC to mitigate data gaps and ensure that state and local immunization programs are aware of existing tools to address vaccination campaign needs.
Date: 01/2023
Type: Document
Sponsoring organization: Office of Inspector General (HHS)
view details
Presents results of a December 2021 survey of 56 state and local immunization programs regarding whether they receive individual-level COVID-19 vaccination data from Federal agencies and retail pharmacy partners. Discusses the impact of having incomplete individual-level vaccination data on reaching unvaccinated and vulnerable populations, including rural populations and American Indians and Alaska Natives (AI/ANs). Includes recommendations for the CDC to mitigate data gaps and ensure that state and local immunization programs are aware of existing tools to address vaccination campaign needs.
Date: 01/2023
Type: Document
Sponsoring organization: Office of Inspector General (HHS)
view details
Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic
Results of a study of 1,768 clinicians treating 11,801 patients with opioid use disorder (OUD), to examine the association between telemedicine adoption during the COVID-19 pandemic and indicators of OUD treatment quality. Explores medications for OUD (MOUD) prescribing and OUD-related clinical events, including drug overdose, inpatient detoxification, and rehabilitation center stay. Features statistics including patient and clinician characteristics, with breakdowns by metropolitan, micropolitan, small town, and rural location.
Author(s): Ruth Hailu, Ateev Mehrotra, Haiden A. Huskamp, Alisa B. Busch, Michael L. Barnett
Citation: JAMA Network Open, 6(1)
Date: 01/2023
Type: Document
view details
Results of a study of 1,768 clinicians treating 11,801 patients with opioid use disorder (OUD), to examine the association between telemedicine adoption during the COVID-19 pandemic and indicators of OUD treatment quality. Explores medications for OUD (MOUD) prescribing and OUD-related clinical events, including drug overdose, inpatient detoxification, and rehabilitation center stay. Features statistics including patient and clinician characteristics, with breakdowns by metropolitan, micropolitan, small town, and rural location.
Author(s): Ruth Hailu, Ateev Mehrotra, Haiden A. Huskamp, Alisa B. Busch, Michael L. Barnett
Citation: JAMA Network Open, 6(1)
Date: 01/2023
Type: Document
view details
Travel Times to Facilities Offering Oral Medication Therapy for COVID-19
Results of a study exploring accessibility of oral COVID-19 therapeutics across the United States, by examining travel times to places where these medications are available. Features a county-level map with shadings showing ranges of travel time by census tract.
Author(s): Peter A. Kahn, Xiaohan Ying, Walter S. Mathis
Citation: JAMA Network Open, 6(1)
Date: 01/2023
Type: Document
view details
Results of a study exploring accessibility of oral COVID-19 therapeutics across the United States, by examining travel times to places where these medications are available. Features a county-level map with shadings showing ranges of travel time by census tract.
Author(s): Peter A. Kahn, Xiaohan Ying, Walter S. Mathis
Citation: JAMA Network Open, 6(1)
Date: 01/2023
Type: Document
view details
Number of Health Care Facilities per 100,000 Rural and Urban (Pennsylvania) Residents
Provides statistics for Pennsylvania hospitals, Federally Qualified Health Centers, Rural Health Clinics, skilled nursing facilities, pharmacies, physicians and dentists offices, and residential mental health/substance abuse facilities.
Date: 2023
Type: Document
Sponsoring organization: Center for Rural Pennsylvania
view details
Provides statistics for Pennsylvania hospitals, Federally Qualified Health Centers, Rural Health Clinics, skilled nursing facilities, pharmacies, physicians and dentists offices, and residential mental health/substance abuse facilities.
Date: 2023
Type: Document
Sponsoring organization: Center for Rural Pennsylvania
view details
Experiences with Health Care Access, Cost, and Coverage: Findings from the 2022 KFF Women's Health Survey
Presents findings from the 2022 KFF Women's Health Survey of 5,145 women ages 18-64 who were asked about their health status, use of prescription medications, accessibility to healthcare, their selected care sites, check-ups, use of telemedicine, and health coverage and costs. Includes data on telehealth services provided by urban and rural location.
Author(s): Michelle Long, Brittni Frederiksen, Usha Ranji Alina Salganicoff, Karen Diep
Date: 12/2022
Type: Document
Sponsoring organization: KFF
view details
Presents findings from the 2022 KFF Women's Health Survey of 5,145 women ages 18-64 who were asked about their health status, use of prescription medications, accessibility to healthcare, their selected care sites, check-ups, use of telemedicine, and health coverage and costs. Includes data on telehealth services provided by urban and rural location.
Author(s): Michelle Long, Brittni Frederiksen, Usha Ranji Alina Salganicoff, Karen Diep
Date: 12/2022
Type: Document
Sponsoring organization: KFF
view details
How the COVID-19 Pandemic Changed Urban and Rural Spending Habits
A collection of charts showing changes in spending in urban and rural areas in 2019 compared to 2020. Includes data on healthcare expenditures, including medical supplies, medical services, health insurance, and prescription drugs. Also covers spending related to food, transportation, and more.
Date: 12/2022
Type: Website
Sponsoring organization: Bureau of Labor Statistics
view details
A collection of charts showing changes in spending in urban and rural areas in 2019 compared to 2020. Includes data on healthcare expenditures, including medical supplies, medical services, health insurance, and prescription drugs. Also covers spending related to food, transportation, and more.
Date: 12/2022
Type: Website
Sponsoring organization: Bureau of Labor Statistics
view details
30 Years Of 340B: Preserving The Health Care Safety Net
Discusses the development and purpose of the 340B Drug Pricing Program, and provides an overview of the program. Summarizes research on the impact of the 340B program on hospitals and lessons learned.
Author(s): Henry A. Waxman
Citation: Health Affairs Forefront
Date: 12/2022
Type: Document
view details
Discusses the development and purpose of the 340B Drug Pricing Program, and provides an overview of the program. Summarizes research on the impact of the 340B program on hospitals and lessons learned.
Author(s): Henry A. Waxman
Citation: Health Affairs Forefront
Date: 12/2022
Type: Document
view details